childhood cancer research; commission
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Overview
This bill establishes a fund and a commission to support research into childhood cancer and rare childhood diseases. The fund will be financed through legislative appropriations, donations, and federal grants, and will be used to provide grants to nonprofit health care providers and research institutions in Arizona. A newly created commission will oversee the grant application process and ensure transparency in the allocation of funds.
Key provisions
- Creates a Childhood Cancer and Rare Childhood Disease Research Fund.
- Establishes a Childhood Cancer and Rare Childhood Disease Research Commission with specific member requirements.
- The commission will oversee the selection of clinical trials for research grants.
- Grants from the fund can be used for collaborative research with facilities outside of Arizona.
- Nonprofit organizations receiving grants must use the funds for pediatric cancer or rare pediatric disease research.
- The commission must submit an annual report detailing grant awards and research outcomes.
- Monies in the fund are continuously appropriated.
- The director shall allocate monies in the fund annually.
Who is affected
- Children with cancer and rare childhood diseases
- Health care providers and research institutions in Arizona
- Nonprofit organizations
- Families of children with cancer and rare childhood diseases
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
1 on record
Primary sponsor
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours